The U.S. Supreme Court ruled on Roundup weedkiller cancer claims, blocking certain lawsuits against Bayer. The decision addresses a case involving the EPA-approved product and limits state tort actions based on federal preemption.
The ruling shields Bayer from liability for glyphosate-related harms by allowing federal EPA approval to preempt state claims.
“Corporate protections and regulatory capture over public health accountability”
The decision checks excessive litigation against products regulators have deemed safe, supporting agricultural innovation.
“Judicial restraint and economic growth versus unchecked tort actions”
Federal preemption reduces piecemeal litigation that burdens companies without democratic input, though it risks over-trusting regulators.
“Property rights and market mechanisms versus expansive liability”
All views overstate the ruling as decisive corporate victory while ignoring narrower claim limits and conflicting scientific data on causation.
“Technical scope of preemption and evidentiary issues in prior cases”
Supreme Court Issues Ruling Blocking Roundup Cancer Lawsuits You are here